|
1
|
Saravanan R, Mohanram H, Joshi M, et al:
Structure, activity and interactions of the cysteine deleted analog
of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic
insights into outer-membrane permeabilization and endotoxin
neutralization. Biochim Biophys Acta. 1818:1613–1624. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Doherty T, Waring AJ and Hong M: Dynamic
structure of disulfide-removed linear analogs of tachyplesin-I in
the lipid bilayer from solid-state NMR. Biochemistry. 47:1105–1116.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Y, Xu X, Hong S, et al:
RGD-Tachyplesin inhibits tumor growth. Cancer Res. 61:2434–2438.
2001.PubMed/NCBI
|
|
4
|
Li QF, Ou-Yang GL, Peng XX and Hong SG:
Effects of tachyplesin on the regulation of cell cycle in human
hepatocarcinoma SMMC-7721 cells. World J Gastroenterol. 9:454–458.
2003.PubMed/NCBI
|
|
5
|
Shi SL, Wang YY, Liang Y and Li QF:
Effects of tachyplesin and n-sodium butyrate on proliferation and
gene expression of human gastric adenocarcinoma cell line BGC-823.
World J Gastroenterol. 12:1694–1698. 2006.PubMed/NCBI
|
|
6
|
Wu XZ and Xie GR: Induced differentiation
of hepatocellular carcinoma by natural products. Afr J Tradit
Complement Altern Med. 5:325–331. 2008.PubMed/NCBI
|
|
7
|
Eyler CE, Wu Q, Yan K, et al: Glioma stem
cell proliferation and tumor growth are promoted by nitric oxide
synthase-2. Cell. 146:53–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar
|
|
9
|
Gu C, Banasavadi-Siddegowda YK, Joshi K,
et al: Tumor-specific activation of the C-JUN/MELK pathway
regulates glioma stem cell growth in a p53-dependent manner. Stem
Cells. 31:870–881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bleau AM, Howard BM, Taylor LA, et al: New
strategy for the analysis of phenotypic marker antigens in brain
tumor-derived neurospheres in mice and humans. Neurosurg Focus.
24:E282008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mo LJ, Ye HX, Mao Y, et al: B7-H4
expression is high in human U251 glioma stem-like cells and is
induced in monocytes cultured in U251 stem-like cell conditioned
medium. Chin J Cancer. 32:653–660. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rahman M, Deleyrolle L, Vedam-Mai V, et
al: The cancer stem cell hypothesis: failures and pitfalls.
Neurosurgery. 68:531–545. 2011. View Article : Google Scholar
|
|
13
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
14
|
Vermeulen L, Sprick MR, Kemper K, Stassi G
and Medema JP: Cancer stem cells - old concepts, new insights. Cell
Death Differ. 15:947–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Todaro M, Francipane MG, Medema JP and
Stassi G: Colon cancer stem cells: promise of targeted therapy.
Gastroenterology. 138:2151–2162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vermeulen L, de Sousa e Melo F, Richel DJ
and Medema JP: The developing cancer stem-cell model: clinical
challenges and opportunities. Lancet Onco. 13:e83–e89. 2012.
View Article : Google Scholar
|
|
17
|
Akita M, Tanaka K, Murai N, et al:
Detection of CD133 (prominin-1) in a human hepatoblastoma cell line
(HuH-6 clone 5). Microsc Res Tech. 76:844–852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sellheyer K: Stem cell markers can help
identify adnexal tumor differentiation when evaluated in the
context of morphology: methodology matters. J Cutan Pathol.
38:460–474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue Z, Yan H, Li J, et al: Identification
of cancer stem cells in vincristine preconditioned SGC7901 gastric
cancer cell line. J Cell Biochem. 113:302–312. 2012. View Article : Google Scholar
|
|
20
|
Folkins C, Man S, Xu P, Shaked Y, Hicklin
DJ and Kerbel RS: Anticancer therapies combining antiangiogenic and
tumor cell cytotoxic effects reduce the tumor stem-like cell
fraction in glioma xenograft tumors. Cancer Res. 67:3560–3564.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu SC, Xiao HL, Jiang XF, et al: Connexin
43 reverses malignant phenotypes of glioma stem cells by modulating
E-cadherin. Stem Cells. 30:108–120. 2012. View Article : Google Scholar
|
|
22
|
Pollard SM, Yoshikawa K, Clarke ID, et al:
Glioma stem cell lines expanded in adherent culture have
tumor-specific phenotypes and are suitable for chemical and genetic
screens. Cell Stem Cell. 4:568–580. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji B, Chen Q, Liu B, et al: Glioma stem
cell-targeted dendritic cells as a tumor vaccine against malignant
glioma. Yonsei Med J. 54:92–100. 2013. View Article : Google Scholar
|
|
24
|
Chen J, Xu XM, Underhill CB, et al:
Tachyplesin activates the classic complement pathway to kill tumor
cells. Cancer Res. 65:4614–4622. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li QF, Ouyang GL, Liu QR and Hong SG:
Tachyplesin-induced differentiation of human hepatocarcinoma cell
line SMMC-7721. Ai Zheng. 21:480–483. 2002.(In Chinese). PubMed/NCBI
|
